| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/28/2013 | US8450558 Loci associated charcoal rot drought complex tolerance in soybean |
| 05/28/2013 | US8450474 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 05/28/2013 | US8450472 Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450460 Single-chain TNFSF fusion polypeptides |
| 05/28/2013 | US8450457 T1R taste receptors and genes encoding same |
| 05/28/2013 | US8450292 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm |
| 05/28/2013 | US8450291 RNA antagonist compounds for the modulation of PIK3CA expression |
| 05/28/2013 | US8450289 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 05/28/2013 | US8450279 Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 05/28/2013 | US8450267 GRG23 EPSP synthases: compositions and methods of use |
| 05/28/2013 | US8450247 Cell display libraries |
| 05/28/2013 | US8450110 Human neuronal progenitor cells co-expressing nestin and Pax6, and co-expressing NeuN or Tuj1 |
| 05/28/2013 | US8450107 Nucleotide-specific recognition sequences for designer TAL effectors |
| 05/28/2013 | US8450106 Oncolytic virus |
| 05/28/2013 | US8450098 Method for introducing nucleic acids into fungal cells |
| 05/28/2013 | US8450093 Adaptive engineering of clostridium for increased butanol production |
| 05/28/2013 | US8450091 Perhydrolase providing improved specific activity |
| 05/28/2013 | US8450087 Use of triplex structure DNA in transferring nucleotide sequences |
| 05/28/2013 | US8450066 Methods for identifying the activity of gene products |
| 05/28/2013 | US8450060 Lafora's disease gene |
| 05/28/2013 | US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 05/28/2013 | US8449876 Human lysosomal proteins from plant cell culture |
| 05/28/2013 | US8449875 Targeting pseudotyped retroviral vectors |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
| 05/28/2013 | CA2693274C Peptide acceptor ligation methods |
| 05/28/2013 | CA2647451C Process for the production of carotenoid compositions |
| 05/28/2013 | CA2641226C Soybean isopentenyl transferase genes and methods of use |
| 05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/28/2013 | CA2578564C Method of error reduction in nucleic acid populations |
| 05/28/2013 | CA2570786C Modified cpg-containing oligonucleotide multimers in immune stimulation |
| 05/28/2013 | CA2556855C Composition and method for enhancing plant transformation and homologous recombination |
| 05/28/2013 | CA2554784C Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/28/2013 | CA2542192C Look-through mutagenesis |
| 05/28/2013 | CA2520811C Method of cdna synthesis |
| 05/28/2013 | CA2517258C Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2502904C Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| 05/28/2013 | CA2489595C Recombination of nucleic acid library members |
| 05/28/2013 | CA2483145C Transgenic plants with controlled distribution of a trait to progeny |
| 05/28/2013 | CA2481108C Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2472886C Transgenic plants expressing civps or intein modified proteins and related method |
| 05/28/2013 | CA2468235C Nucleic acid linkers and their use in gene synthesis |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2459367C Methods for construction and screening of libraries of chemokine variants |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2451443C Hyaluronan synthase genes and expression thereof |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/28/2013 | CA2434802C Isolating cells expressing secreted proteins |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2412239C Cytokine receptor zcytor17 |
| 05/28/2013 | CA2411740C Improved combinatorial libraries by recombination in yeast and analysis method |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2324513C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/28/2013 | CA2280997C Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 05/28/2013 | CA2256757C Method of producing l-serine by fermentation |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013075140A1 Auto -recognizing therapeutic rna/dna chimeric nanoparticles (np) |
| 05/23/2013 | WO2013075132A1 Therapeutic rna switches compositions and methods of use |
| 05/23/2013 | WO2013075131A1 Cytoplasm to organelle delivery system and associated methods |
| 05/23/2013 | WO2013075079A1 System and methods for selective molecular analysis |
| 05/23/2013 | WO2013075035A1 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases |
| 05/23/2013 | WO2013074999A1 Modified dna-binding proteins and uses thereof |
| 05/23/2013 | WO2013074974A2 Modified rnai agents |
| 05/23/2013 | WO2013074927A1 Method for isolating total rna from cells |
| 05/23/2013 | WO2013074916A1 Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
| 05/23/2013 | WO2013074911A1 Blue-light inducible system for gene expression |
| 05/23/2013 | WO2013074885A1 Microfluidic apparatus, method, and applications |
| 05/23/2013 | WO2013074857A1 Methods for determining risks of cancer |
| 05/23/2013 | WO2013074833A1 Capture probe and assay for analysis of fragmented nucleic acids |
| 05/23/2013 | WO2013074785A1 Selective detection of norovirus |
| 05/23/2013 | WO2013074738A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/23/2013 | WO2013074632A1 Mismatch nucleotide purification and identification |
| 05/23/2013 | WO2013074601A1 Gamma-pna miniprobes for fluorescent labeling |
| 05/23/2013 | WO2013074489A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | WO2013074438A1 Differential identification of pancreatic cysts |
| 05/23/2013 | WO2013074163A1 Quantitative, highly multiplexed detection of nucleic acids |
| 05/23/2013 | WO2013073860A1 Recombinant microorganism capable of fixing carbon dioxides and method for preparing useful material using same |
| 05/23/2013 | WO2013073774A1 Development of nucleic acid gel matrix for cell-free protein synthesis of cell nucleus replicate, and method for producing same |
| 05/23/2013 | WO2013073760A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase |
| 05/23/2013 | WO2013073725A1 Nanopore structure using oligonucleotide and base sequence determining device containing same |
| 05/23/2013 | WO2013073706A1 Ligand having three-finger structure, and method for detecting molecule using same |
| 05/23/2013 | WO2013073699A1 Protein having glycoalkaloid biosynthase activity, and gene encoding same |
| 05/23/2013 | WO2013073689A1 Plant body expressing pyripyropene biosynthesis gene |
| 05/23/2013 | WO2013073684A1 Marker for diagnosing forelimb-girdle muscular anomaly in mammal individual, and detection method using same |
| 05/23/2013 | WO2013073679A1 Method for producing (2r,4r)-monatin polyvalent metal salt crystals |
| 05/23/2013 | WO2013073667A1 Intestinal fibrosis treatment agent |
| 05/23/2013 | WO2013073653A1 Method for inducing proteolysis in eukaryotic cell |
| 05/23/2013 | WO2013073602A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | WO2013073576A1 Nucleic acid molecule for inhibiting activity of rnai molecule |
| 05/23/2013 | WO2013073545A1 Medicine for treatment and/or improvement of sepsis |
| 05/23/2013 | WO2013073483A1 Method for producing myo-inositol and myo-inositol derivative |
| 05/23/2013 | WO2013073246A1 Method of inducing differentiation from pluripotent stem cells to skeletal muscle cells |
| 05/23/2013 | WO2013073219A1 Method for producing insoluble aggregate of neurodegenerative-disease-related protein |